Inventor
Kevin J. Tomaselli
Inventor
San Diego, CA, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07KPeptides16%
C12NMicroorganisms or enzymes13%
A01NPreservation of bodies of humans or animals or plants or parts thereof8%
C07CAcyclic or carbocyclic compounds6%
A61QSpecific use of cosmetics or similar toiletry preparations5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
A61JContainers specially adapted for medical or pharmaceutical purposes3%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers3%
PatentTitleYear
8,226,986'Liquid chalcogenide compositions and methods of manufacturing and using the same'20127,923,037'Liquid chalcogenide compositions and methods of manufacturing and using the same'20116,969,703'Inhibitors of the ICE/ced-3 family of cysteine proteases'20056,897,296'Antibody that specifically binds an Mch5 polypeptide'20056,790,989'Inhibitors of the ICE/ced-3 family of cysteine proteases'20046,730,779'Antibody that specifically binds an Mch4 polypeptide'20046,716,960'Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use'20046,693,096'Treatment of inflammation-associated disorders using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20046,686,459'Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use'20046,610,683'Treatment of infectious disease using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20036,531,467'Inhibition of inflammation using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20036,528,506'Inhibition of apoptosis using interleukin-1-converting enzyme (ICE)/CED-3 family inhibitors'20036,525,024'Inhibitors of the ICE/ced-3 family of cysteine proteases'20036,518,032'Rapid methods for identifying modifiers of cellular apoptosis activity'20036,515,173'Inhibitors of the ICE/ced-3 family of cysteine proteases'20036,462,175'Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use'20026,287,795'Mch4 and Mch5, apoptotic protease, nucleic acids encoding and methods of use'20016,270,980'Rapid methods for identifying modifiers of cellular apoptosis activity'20016,251,614'Rapid methods for identifying modifiers of cellular apoptosis activity'20016,200,969'Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ICE)/CED-3 family inhibitors'20015,851,815'MCH4 and MCH5, apoptotic proteases'19985,786,173'MCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of use'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2005Patents assigned to IDUN PHARMACEUTICALS INC (19)· patent assignee history
1998–2004Based in La Jolla, CA, US· patent location history
2001–2005Patents assigned to UNIV JEFFERSON (6)· patent assignee history
2001–2012Based in San Diego, CA, US· patent location history
2011–2012Patents assigned to IKARIA INC (2)· patent assignee history
2012Patents assigned to DECKWERTH THOMAS L (1)· patent assignee history
2012Patents assigned to HILL PAUL A (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IDUN PHARMACEUTICALS INC | 19 | 1998–2005 |
| UNIV JEFFERSON | 6 | 2001–2005 |
| IKARIA INC | 2 | 2011–2012 |
| DECKWERTH THOMAS L | 1 | 2012 |
| HILL PAUL A | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 16 | 2001–2012 |
| La Jolla, California, US | 6 | 1998–2004 |